A former senior scientist at Genentech Inc. and three former colleagues have been indicted on charges of stealing trade secrets from the biotechnology company to give to a rival firm in Taiwan.
Scientist Xanthe Lam, 66, of South San Francisco, worked for Genentech from 1986 until the fall of 2017, according to a grand jury indictment issued Oct. 25 and unsealed on Monday.
The other defendants are her husband, Allen Lam, 68, of South San Francisco, who worked in quality control for Genentech from 1989 to 1998; James Quach, 58, of Daly City, a former Genentech engineer; and John Chan, 29, of San Francisco, a former Genentech worker.
Allen Lam, Quach and Chan all became consultants for the competitor, JHL Biotech Inc. of Zhubei, Taiwan, at times between 2013 and 2017. JHL was seeking to make drugs known as biosimilars, the equivalent of generic drugs.
The indictment alleges that Xanthe Lam began secretly working for JHL while still employed at South San Francisco-based Genentech and funneled trade secrets from Genentech to JHL Biotech through Allen Lam, Quach and Chan between 2013 and 2017.
The defendants are charged with conspiring to steal trade secrets, as well as with additional counts of theft of trade secrets, computer fraud or both.
They made initial appearances before U.S. Magistrate Joseph Spero on Monday and were released on bond. Xanthe Lam, Allen Lam and Chan pleaded not guilty to the charges. Quach’s arraignment was delayed until Nov. 2 so that his defense attorney can be identified.
The four defendants are due to appear before U.S. District Judge William Alsup, the trial judge assigned to the case, on Nov. 13 for the setting of future court dates.
Keep the discussion civilized. Absolutely NO
personal attacks or insults directed toward writers, nor others who
make comments. Keep it clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. Don't threaten. Threats of harming another
person will not be tolerated. Be truthful. Don't knowingly lie about anyone
or anything. Be proactive. Use the 'Report' link on
each comment to let us know of abusive posts. PLEASE TURN OFF YOUR CAPS LOCK. Anyone violating these rules will be issued a
warning. After the warning, comment privileges can be
revoked.
Please purchase a Premium Subscription to continue reading.
To continue, please log in, or sign up for a new account.
We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.
A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!
(0) comments
Welcome to the discussion.
Log In
Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.